#autoinjectors market was valued at USD 1,100 million in 2022 and is expected to reach USD 2,491 million by 2033, growing at a CAGR of 13.5%. Autoinjectors, used for easy self-administration of medication, are gaining traction in treating chronic conditions like rheumatoid arthritis, multiple sclerosis, and diabetes.
Read More: https://wemarketresearch.com/r....eports/autoinjectors
#healthcareinnovation #medicaldevices #chronicdiseasecare #selfinjection #pharmatrends